Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07768566
NA

Intranasal Dexmedetomidine vs. Oral Chloral Hydrate for Pediatric Orthopedic Procedural Sedation

Sponsor: Seoul National University Childrens Hospital

View on ClinicalTrials.gov

Summary

This prospective randomized controlled study will compare the effectiveness and safety of intranasal dexmedetomidine with oral chloral hydrate for procedural sedation in children undergoing painful orthopedic manipulation. Forty-four children 7 to 12 years of age will be assigned in a 1:1 ratio to receive either intranasal dexmedetomidine 3 micrograms/kg plus oral saline or oral chloral hydrate 50 mg/kg plus intranasal saline. Both the participants and the clinicians performing the procedure will be blinded to treatment assignment. The primary outcome is successful sedation throughout the procedure, defined as a Pediatric Sedation State Scale (PSSS) score maintained between 1 and 4. Secondary outcomes include time to sedation, recovery time, sedation without movement, need for rescue sedation, vital-sign safety events, other adverse events, and participant, parent, and clinician satisfaction.

Official title: Procedural Sedation With Intranasal Dexmedetomidine Versus Oral Chloral Hydrate for Painful Orthopedic Manipulation: A Prospective Randomized Controlled Study

Key Details

Gender

All

Age Range

7 Years - 12 Years

Study Type

INTERVENTIONAL

Enrollment

44

Start Date

2026-09-01

Completion Date

2028-12-31

Last Updated

2026-08-17

Healthy Volunteers

No

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine 3 micrograms/kg administered intranasally through a mucosal atomizer device 30 minutes before the planned procedure. The dose is divided between both nostrils.

DRUG

Chloral Hydrate

Chloral hydrate 50 mg/kg administered orally 30 minutes before the planned procedure.

DRUG

Intranasal Saline Placebo

An equal volume of normal saline administered intranasally 30 minutes before the planned procedure to maintain the double-dummy masking.

DRUG

Oral Saline Placebo

An equal volume of normal saline administered orally 30 minutes before the planned procedure to maintain the double-dummy masking.

Locations (1)

Seoul National University Hospital

Seoul, Seoul, South Korea